Fernando Vieira

Company: ALS Therapy Development Institute
Job title: CEO and Chief Science Officer
Seminars:
An On-Going ALS Natural History Study to Distinguish Patient Subpopulations & Identify Novel Biomarkers 9:00 am
• Identifying biomarkers to distinguish ALS patient subpopulations for optimized clinical trial recruitment • Connecting biomarkers and target discovery to reveal ALS biology engaged in different subpopulations • Building data to apply approaches for predicting ALS susceptibility and early disease diagnosisRead more
day: Day Two AM